vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and PagerDuty, Inc. (PD). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $124.5M, roughly 1.7× PagerDuty, Inc.). PagerDuty, Inc. runs the higher net margin — 129.7% vs 57.4%, a 72.4% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $24.1M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.
IDYA vs PD — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $124.5M |
| Net Profit | $119.2M | $161.6M |
| Gross Margin | — | 85.3% |
| Operating Margin | 52.2% | 6.5% |
| Net Margin | 57.4% | 129.7% |
| Revenue YoY | — | 4.7% |
| Net Profit YoY | 330.1% | 2827.7% |
| EPS (diluted) | $1.33 | $1.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $124.5M | ||
| Q3 25 | $207.8M | $123.4M | ||
| Q2 25 | — | $119.8M | ||
| Q1 25 | — | $121.4M | ||
| Q4 24 | — | $118.9M | ||
| Q3 24 | $0 | $115.9M | ||
| Q2 24 | $0 | $111.2M | ||
| Q1 24 | $0 | $111.1M |
| Q4 25 | — | $161.6M | ||
| Q3 25 | $119.2M | $9.6M | ||
| Q2 25 | — | $-7.2M | ||
| Q1 25 | — | $-8.8M | ||
| Q4 24 | — | $-5.9M | ||
| Q3 24 | $-51.8M | $-10.9M | ||
| Q2 24 | $-52.8M | $-17.1M | ||
| Q1 24 | $-39.6M | $-28.2M |
| Q4 25 | — | 85.3% | ||
| Q3 25 | — | 84.6% | ||
| Q2 25 | — | 84.0% | ||
| Q1 25 | — | 83.6% | ||
| Q4 24 | — | 83.0% | ||
| Q3 24 | — | 82.7% | ||
| Q2 24 | — | 82.6% | ||
| Q1 24 | — | 81.7% |
| Q4 25 | — | 6.5% | ||
| Q3 25 | 52.2% | 2.9% | ||
| Q2 25 | — | -8.6% | ||
| Q1 25 | — | -9.6% | ||
| Q4 24 | — | -8.7% | ||
| Q3 24 | — | -13.8% | ||
| Q2 24 | — | -19.5% | ||
| Q1 24 | — | -30.1% |
| Q4 25 | — | 129.7% | ||
| Q3 25 | 57.4% | 7.8% | ||
| Q2 25 | — | -6.0% | ||
| Q1 25 | — | -7.2% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | — | -9.4% | ||
| Q2 24 | — | -15.4% | ||
| Q1 24 | — | -25.3% |
| Q4 25 | — | $1.69 | ||
| Q3 25 | $1.33 | $0.10 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.12 | ||
| Q4 24 | — | $-0.07 | ||
| Q3 24 | $-0.60 | $-0.14 | ||
| Q2 24 | $-0.68 | $-0.26 | ||
| Q1 24 | $-0.53 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $547.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $320.5M |
| Total Assets | $1.2B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $547.8M | ||
| Q3 25 | $786.9M | $567.9M | ||
| Q2 25 | — | $597.1M | ||
| Q1 25 | — | $570.8M | ||
| Q4 24 | — | $542.2M | ||
| Q3 24 | $920.0M | $599.3M | ||
| Q2 24 | $701.7M | $592.8M | ||
| Q1 24 | $698.8M | $571.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $484.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $489.5M |
| Q4 25 | — | $320.5M | ||
| Q3 25 | $1.1B | $180.7M | ||
| Q2 25 | — | $145.7M | ||
| Q1 25 | — | $129.8M | ||
| Q4 24 | — | $111.6M | ||
| Q3 24 | $1.2B | $164.7M | ||
| Q2 24 | $931.7M | $174.0M | ||
| Q1 24 | $935.3M | $171.6M |
| Q4 25 | — | $1.0B | ||
| Q3 25 | $1.2B | $891.5M | ||
| Q2 25 | — | $926.8M | ||
| Q1 25 | — | $927.3M | ||
| Q4 24 | — | $866.8M | ||
| Q3 24 | $1.2B | $916.0M | ||
| Q2 24 | $973.7M | $924.0M | ||
| Q1 24 | $961.5M | $925.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.73× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $24.8M |
| Free Cash FlowOCF − Capex | $142.2M | $24.1M |
| FCF MarginFCF / Revenue | 68.4% | 19.3% |
| Capex IntensityCapex / Revenue | 0.0% | 0.6% |
| Cash ConversionOCF / Net Profit | 1.19× | 0.15× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $24.8M | ||
| Q3 25 | $142.2M | $34.0M | ||
| Q2 25 | — | $30.7M | ||
| Q1 25 | — | $31.4M | ||
| Q4 24 | — | $22.1M | ||
| Q3 24 | $-49.2M | $35.8M | ||
| Q2 24 | $-32.9M | $28.6M | ||
| Q1 24 | $-43.8M | $22.2M |
| Q4 25 | — | $24.1M | ||
| Q3 25 | $142.2M | $33.1M | ||
| Q2 25 | — | $30.2M | ||
| Q1 25 | — | $30.3M | ||
| Q4 24 | — | $21.5M | ||
| Q3 24 | $-49.7M | $35.1M | ||
| Q2 24 | $-33.9M | $28.2M | ||
| Q1 24 | $-45.1M | $21.2M |
| Q4 25 | — | 19.3% | ||
| Q3 25 | 68.4% | 26.8% | ||
| Q2 25 | — | 25.2% | ||
| Q1 25 | — | 24.9% | ||
| Q4 24 | — | 18.1% | ||
| Q3 24 | — | 30.3% | ||
| Q2 24 | — | 25.4% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | — | 0.6% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | — | 0.15× | ||
| Q3 25 | 1.19× | 3.55× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
